One Source Industries Opens San Pedro, California, Production Facility
07/13/2015
The new facility will provide contract packaging, fulfillment, distribution and product pack-out services for customers in the consumer electronics market and other industries. Opening with an initial 10 employees, the new facility is poised for additional growth in the coming years, company officials said.
“We’re excited to continue to increase our capacity to better serve our customers, particularly on the West Coast. The San Pedro facility complements our other production facilities in Chicago, Illinois and Memphis, Tennessee. The new San Pedro facility will provide faster speed-to-market for our customers and meets our need for increased production capabilities as a result of two consecutive years of double-digit growth,” said Joe Baksha, President/CEO of OSI.
Headquartered in Irvine, California, the San Pedro facility is OSI’s second California location. In addition to its Chicago and Memphis locations, OSI also has facilities in Bentonville, Arkansas; New York, New York and Hong Kong.
Project Announcements
Kratos Plans Somerset County, Maryland, Production Operations
01/17/2026
CesiumAstro Expands Bee Cave, Texas, Headquarters-Manufacturing Operations
01/16/2026
Johnson & Johnson Expands Wilson County, North Carolina, Production Operations
01/16/2026
Solstice Advanced Materials Expands Chesterfield County, Virginia, Manufacturing Operations
01/16/2026
TransMedics Group Plans Somerville, Massachusetts, Headquarters Operations
01/16/2026
AVAIO Digital Partners Plans Pulaski County, Arkansas, Data Center Operations
01/14/2026
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
The New Industrial Revolution in Biotech
Q4 2025